
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.11 | 0.11 | 0.00 |
Shares | 90.41 | 90.41 | 0.00 |
Convertible | 0.14 | 0.14 | 0.00 |
Other | 9.35 | 9.35 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.65 | 19.45 |
Price to Book | 4.67 | 4.49 |
Price to Sales | 2.21 | 2.56 |
Price to Cash Flow | 19.64 | 17.33 |
Dividend Yield | 0.67 | 1.10 |
5 Years Earnings Growth | 10.38 | 12.17 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.92 | 99.66 |
Financial Services | 0.08 | 0.49 |
Number of long holdings: 151
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.42 | 813.48 | +1.48% | |
Aggregate Miscellaneous Equity | - | 9.35 | - | - | |
UnitedHealth | US91324P1021 | 6.21 | 488.65 | +1.48% | |
Intuitive Surgical | US46120E6023 | 5.99 | 484.44 | +1.61% | |
Thermo Fisher Scientific | US8835561023 | 5.03 | 522.05 | +2.58% | |
Stryker | US8636671013 | 4.33 | 369.53 | +1.61% | |
argenx ADR | US04016X1019 | 3.72 | 604.96 | +4.09% | |
Danaher | US2358511028 | 3.36 | 210.74 | +3.26% | |
Boston Scientific | US1011371077 | 2.91 | 97.16 | +1.88% | |
Vertex | US92532F1003 | 2.80 | 504.77 | +0.37% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 34.03B | 1.96 | 8.05 | 10.42 | ||
T. Rowe Price Blue Chip Growth | 28.2B | -0.83 | 13.21 | 14.08 | ||
T. Rowe Price Capital AppreciationI | 28.62B | 1.99 | 8.19 | - | ||
T. Rowe Price Blue Chip Growth I | 26.03B | -0.80 | 13.36 | - | ||
T. Rowe Price Instl Large Cap Growt | 19.94B | 0.04 | 13.08 | 15.45 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review